Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats
- 1 April 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 873, 172960
Abstract
No abstract availableKeywords
Funding Information
- Sultan Qaboos University (IG/MED/PHAR/18/01)
This publication has 25 references indexed in Scilit:
- Impaired renal function and development in Belgrade ratsAmerican Journal of Physiology-Renal Physiology, 2014
- Levosimendan Protection against Kidney Ischemia/Reperfusion Injuries in Anesthetized PigsThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Effect of short-term treatment with levosimendan on oxidative stress in renal tissues of ratsToxicology and Industrial Health, 2012
- Impaired Tubular Uptake Explains Albuminuria in Early Diabetic NephropathyJournal of the American Society of Nephrology, 2009
- Four-week administration of nimesulide, a cyclooxygenase-2 inhibitor, improves endothelial dysfunction in the hindlimb vasculature of streptozotocin-induced diabetic ratsArchives of Pharmacal Research, 2008
- The influence of levosimendan and iloprost on renal ischemia-reperfusion: an experimental studyInteractive CardioVascular and Thoracic Surgery, 2007
- Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic ratsActa Diabetologica, 2007
- Levosimendan protects against experimental endotoxemic acute renal failureAmerican Journal of Physiology-Renal Physiology, 2006
- Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failureThe American Journal of Cardiology, 2004
- Role of Prostaglandin E Receptor EP 1 Subtype in the Development of Renal Injury in Genetically Hypertensive RatsHypertension, 2003